A DOSE-RANGING STUDY TO EVALUATE EFFICACY AND SAFETY OF PF-06700841 IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
Clinical trial NCT03845517 · COMPLETED
Trial details
- NCT number
- NCT03845517
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-18
- Primary completion
- 2023-10-05
- Enrollment
- 350
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.